Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ani Pharmaceuticals (ANIP) Change in Inventory: 2012-2024

Historic Change in Inventory for Ani Pharmaceuticals (ANIP) over the last 13 years, with Dec 2024 value amounting to $21.3 million.

  • Ani Pharmaceuticals' Change in Inventory rose 28.30% to $8.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.4 million, marking a year-over-year decrease of 58.88%. This contributed to the annual value of $21.3 million for FY2024, which is 264.44% up from last year.
  • Per Ani Pharmaceuticals' latest filing, its Change in Inventory stood at $21.3 million for FY2024, which was up 264.44% from $5.8 million recorded in FY2023.
  • In the past 5 years, Ani Pharmaceuticals' Change in Inventory registered a high of $23.6 million during FY2022, and its lowest value of -$3.2 million during FY2021.
  • Moreover, its 3-year median value for Change in Inventory was $21.3 million (2024), whereas its average is $16.9 million.
  • As far as peak fluctuations go, Ani Pharmaceuticals' Change in Inventory crashed by 216.85% in 2021, and later spiked by 832.82% in 2022.
  • Ani Pharmaceuticals' Change in Inventory (Yearly) stood at $2.8 million in 2020, then tumbled by 216.85% to -$3.2 million in 2021, then soared by 832.82% to $23.6 million in 2022, then crashed by 75.28% to $5.8 million in 2023, then soared by 264.44% to $21.3 million in 2024.